Roboleo & Co retweeted
The Innovative Devices Access Pathway pilot launched today.
It has the potential to expedite patient access to innovative technologies by providing innovators and manufacturers with multi-partner support and targeted scientific advice.
Learn more: gov.uk/government/news/uk-pa… #IDAP

ALT Jeanette Kusel, Director of NICE Scientific Advice, said: "At NICE we’re committed to focussing on what matters most to patients and healthcare providers. This pathway will offer companies the direction they need to properly demonstrate the value of innovations that have the potential to address unmet need in the system."
Roboleo & Co retweeted
Join our webinar on the future of the UK's #AntimicrobialResistance model.
Learn about the subscription model recently piloted in England (and proposals for its expansion), where companies pay a fixed annual fee based on value to the NHS, not volume sold: web.cvent.com/event/da58da2a…
NHS England launches pilot programme for high street pharmacy referrals pmlive.com/pharma_news/nhs_e… via @pmlivecom
EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases pmlive.com/pharma_news/efpia… via @pmlivecom
NICE releases revised guidelines on antidepressants pharmatimes.com/news/nice_re…
Here is the link for the updated NICE Methods and Processes for Health Technology Evaluation with respect to a for Managed Access nice.org.uk/process/pmg36/ch…
NICE charges for Technology Appraisals and Highly Specialised Technologies have been updated and effective from 1 April 2022. The discount for SMEs remains at 75%. nice.org.uk/about/what-we-do…
NICE has confirmed changes to the way it evaluates medicines and other health technologies. This is to ensure patients have earlier access to innovative treatments by offering greater flexibility re: value for money and the evidence base necessary nice.org.uk/about/what-we-do…
1
NICE has today published details of the outcome of the NICE methods and processes review in a paper ahead of tomorrow’s board meeting nice.org.uk/Media/Default/Ge…
First-ever UN Resolution on persons with rare diseases paves the way for Europe’s Action Plan for Rare Diseases eurordis.org/news/un-resolut…
NHS sets aside £340m for new Innovative Medicines Fund pharmaphorum.com/
Gov’t sets out ten-year strategy for the UK’s life sciences sector pharmatimes.com/news/govt_se…
The MHRA has today published its new Delivery Plan 2021-23 - with the focus on delivering meaningful outcomes for patients and protecting public health through excellence in regulation and science. assets.publishing.service.go…
New NHS legislation provides ‘once-in-a-decade opportunity’ to centre research pharmatimes.com/news/new_nhs…
Delighted to announce ROBOLEO & CO now appointed as a NICE META tool facilitating organisation. This process helps developers of med-tech innovations to identify key evidence gaps and optimise their development plans see meta.nice.org.uk and roboleo.com
1
A new Medical Technologies (‘Med Tech’) Directorate in the Department, has been announced by Steve Oldfield, Chief Commercial Officer
NICE 5-year strategy sets out how they'll work across the health and care system and life sciences sector nice.org.uk/about/who-we-are…
The MHRA has published a case study on the Early Access to Medicines Scheme (EAMS). Includes details of a post-EAMS pilot (PEAMS) to bridge the gap between EAMS and routine access, see: gov.uk/government/case-studi…
2


